| 03-Jan-12 | Sanofi-Aventis - Research Laboratories | Vice President, Infectious Disease | France |
| 05-Jan-12 | Photocure ASA | Commercial Head | New Jersey, USA |
| 16-Jan-12 | Sanofi-Aventis - Pasteur | Research & Development Head | China |
| 20-Jan-12 | QuadraMed AG | Chief Financial Officer | Virginia, USA |
| 23-Jan-12 | IMS Health | Senior Principal, Commercial Effectiveness | Pennsylvania, USA |
| 27-Jan-12 | Actelion Ltd. | Associate Compensation & Benefits Director | Switzerland |
| 01-Feb-12 | Sanofi-Aventis - Pharmaceuticals | Human Resources Director | Saudi Arabia |
| 03-Feb-12 | Ipsen SA | Vice President, Facility Management | France |
| 13-Feb-12 | Sanofi-Aventis - Pasteur | Vice President, Regulatory Affairs | France |
| 13-Feb-12 | Spectra-Science Inc. | Business Development Director | Belgium |
| 17-Feb-12 | Cabot-Supermetals | Head of Finance | Massachusetts, USA |
| 20-Feb-12 | CR Bard Inc. | Country Manager | Turkey |
| 28-Feb-12 | Ipsen SA | Head of Operational Excellence - Research & Development | France |
| 05-Mar-12 | Straumann AG | Site Director - Villeret | Switzerland |
| 08-Mar-12 | Rockport Capital Partners - Clean Diesel | Chief Executive Officer | California, USA |
| 15-Mar-12 | Stryker Inc. | Health Economics & Reimbursement Director | Spain |
| 22-Mar-12 | Ipsen SA | Global Clinical Development Head | France |
2012 - 1st Quarter